Acid inactivation of prions: Efficient at elevated temperature or high acid concentration

Journal of General Virology

Volumn 87, Issue 5, 2006, Pages 1385-1394

  Appel, Thomas R ^a,b   Lucassen, Ralf ^b   Groschup, Martin H ^c   Joncic, Marion ^d   Beekes, Michael ^d   Riesner, Detlev ^b  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLORIC ACID; PRION PROTEIN; RECOMBINANT PROTEIN; SOLVENT;

ACIDITY; ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITOMETRY; HIGH TEMPERATURE; HYDROLYSIS KINETICS; INCUBATION TIME; NONHUMAN; PRION; PRIORITY JOURNAL; ROOM TEMPERATURE; SCRAPIE AGENT; STRUCTURAL HOMOLOGY; SYRIAN HAMSTER; TEMPERATURE DEPENDENCE; VIRUS INACTIVATION; VIRUS ISOLATION; WESTERN BLOTTING;

ANIMALS; CRICETINAE; HYDROCHLORIC ACID; HYDROLYSIS; KINETICS; PRPSC PROTEINS; RECOMBINANT PROTEINS; TEMPERATURE;

CRICETINAE; SCRAPIE PRION;

EID: 33646132983     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81426-0     Document Type: Article

References (50)

1. Aguzzi, A. & Heikenwalder, M. (2003). Prion diseases: cannibals and garbage piles. Nature 423, 127-129.
2. Appel, T. R., Dumpitak, C., Matthiesen, U. & Riesner, D. (1999). Prion rods contain an inert polysaccharide scaffold. Biol Chem 380, 1295-1306.
3. Appel, T. R., Wolff, M., von Rheinbaben, F., Heinzel, M. & Riesner, D. (2001). Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. J Gen Virol 82, 465-473.
4. Beekes, M., Baldauf, E. & Diringer, H. (1996). Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol 77, 1925-1934.
5. Brown, P., Rohwer, R. G. & Gajdusek, D. C. (1986). Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 153, 1145-1148.
6. Brown, P., Liberski, P. P., Wolff, A. & Gajdusek, D. C. (1990). Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 161, 467-472.
7. Budka, H., Aguzzi, A., Brown, P. & 7 other authors (1995). Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5, 319-322.
8. Chesebro, B. W. (1991). Transmissible spongiform encephalopathies: scrapie, BSE and related human disorders. Curr Top Microbiol Immunol 172, 1-288.
9. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24, 519-550.
10. Danner, K. (1991). Übertragung spongiformer Encephalopathien durch Arzneimittel, Grundzüge einer Risikobetrachtung. Pharm Ind 53, 614-619 (in German).
11. Darbord, J. C. (1999). Inactivation of prions in daily medical practice. Biomed Pharmacother 53, 34-38.
12. DeArmond, S. J. & Prusiner, S. B. (2003). Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med 23, 1-41.
13. Diener, T. O., McKinley, M. P. & Prusiner, S. B. (1982). Viroids and prions. Proc Natl Acad Sci U S A 79, 5220-5224.
14. Diringer, H., Beekes, M., Özel, M., Simon, D., Queck, I., Cardone, F., Pocchiari, M. & Ironside, J. W. (1997). Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 40, 238-246.
15. Ernst, D. R. & Race, R. E. (1993). Comparative analysis of scrapie agent inactivation methods. J Virol Methods 41, 193-201.
16. Gabizon, R., McKinley, M. P., Groth, D., Westaway, D., DeArmond, S. J., Carlson, G. A. & Prusiner, S. B. (1989). Immunoaffinity purification and neutralization of scrapie prions. Prog Clin Biol Res 317, 583-600.
17. Hörnlimann, B., Riesner, D. & Kretzschmar, H. (editors) (2001). Prionen und Prionkrankheiten. Berlin: Walter de Gruyter (in German).
18. Jakubke, H.-D. & Jeschkeit, H. (1983). Proteins. In Concise Encyclopedia of Biochemistry, pp. 380-381. Translated by T. Scott & M. Brewer. New York: Walter de Gruyter.
19. Jansen, K., Schäfer, O., Birkmann, E., Post, K., Serban, H., Prusiner, S. B. & Riesner, D. (2001). Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Biol Chem 382, 683-691.
20. Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M. & Diringer, H. (1987). Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61, 3688-3693.
21. Kellner, R., Lottspeich, F. & Meyer, H. E. (1999). Microcharacterization of Proteins, 2nd edn, pp. 121-123. Weinheim: Wiley-VCH.
22. Kimberlin, R. H., Walker, C. A., Millson, G. C., Taylor, D. M., Robertson, P. A., Tomlinson, A. H. & Dickinson, A. G. (1983). Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 59, 355-369.
23. Klein, T. R., Kirsch, D., Kaufmann, R. & Riesner, D. (1998). Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 379, 655-666.
24. Legname, G., Baskakov, I. V., Nguyen, H. O. B., Riesner, D., Cohen, F. E., DeArmond, S. J. & Prusiner, S. B. (2004). Synthetic mammalian prions. Science 305, 673-676.
25. Manuelidis, L. (1997). Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol 3, 62-65.
26. Manuelidis, L., Sklaviadis, T. & Manuelidis, E. E. (1987). Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 6, 341-347.
27. Martinsen, T. C., Taylor, D. M., Johnsen, R. & Waldum, H. L. (2002). Gastric acidity protects mice against prion infection? Scand J Gastroenterol 37, 497-500.
28. McKinley, M. P., Bolton, D. C. & Prusiner, S. B. (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62.
29. McKinley, M. P., Meyer, R. K., Kenaga, L., Rahbar, F., Cotter, R., Serban, A. & Prusiner, S. B. (1991). Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65, 1340-1351.
30. Mehlhorn, I., Groth, D., Stöckel, J. & 10 other authors (1996). High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35, 5528-5537.
31. Mould, D. L., Dawson, A. M. & Smith, W. (1965). Scrapie in mice. The stability of the agent to various suspending media, pH and solvent extraction. Res Vet Sci 36, 151-154.
32. Oberthür, R. C. (2001). Die Inaktivierung von Prionen durch Hitze. In Prionen und Prionkrankheiten, pp. 389-398. Edited by B. Hörnlimann, D. Riesner & H. Kretzschmar. Berlin: Walter de Gruyter (in German).
33. Priola, S. A., Chesebro, B. & Caughey, B. (2003). A view from the top - prion diseases from 10,000 feet. Science 300, 917-919.
34. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
35. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-13383.
36. Prusiner, S. B. (2001). Neurodegenerative diseases and prions. N Engl J Med 344, 1516-1526.
37. Prusiner, S. B., Groth, D. F., McKinley, M. P., Cochran, S. P., Bowman, K. A. & Kasper, K. C. (1981). Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci U S A 78, 4606-4610.
38. Prusiner, S. B., Bolton, D. C., Groth, D. F., Bowman, K. A., Cochran, S. P. & McKinley, M. P. (1982a). Further purification and characterization of scrapie prions. Biochemistry 21, 6942-6950.
39. Prusiner, S. B., Cochran, S. P., Groth, D. F., Downey, D. E., Bowman, K. A. & Martinez, H. M. (1982b). Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11, 353-358.
40. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F. & Glenner, G. G. (1983). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358.
41. Riesner, D. (2001). The prion theory: background and basic information. Contrib Microbiol 7, 7-20.
42. Riesner, D., Kellings, K., Post, K., Wille, H., Serban, H., Groth, D., Baldwin, M. A. & Prusiner, S. B. (1996). Disruption of prion rods generates 10-nm spherical particles having high α-helical content and lacking scrapie infectivity. J Virol 70, 1714-1722.
43. Safar, J. G., Kellings, K., Serban, H., Groth, D., Cleaver, J. E., Prusiner, S. B. & Riesner, D. (2005). Search for a prion-specific nucleic acid. J Virol 79, 10796-10806.
44. Somerville, R. A., Oberthür, R. C., Havekost, U., MacDonald, F., Taylor, D. M. & Dickinson, A. G. (2002). Characterization of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem 277, 11084-11089.
45. Taylor, D. M. (2000). Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159, 10-17.
46. Taylor, D. M., Fraser, H., McConnell, I., Brown, D. A., Brown, K. L., Lamza, K. A. & Smith, G. R. A. (1994). Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 139, 313-326.
47. Taylor, D. M., Fernie, K., Steele, P. J., McConnell, I. & Somerville, R. A. (2002). Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol 83, 3199-3204.
48. Weissmann, C. (1991). A 'unified theory' of prion propagation. Nature 352, 679-683.
49. Wille, H., Prusiner, S. B. & Cohen, F. E. (2000). Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein. J Struct Biol 130, 323-338.
50. Wille, H., Michelitsch, M. D., Guénebaut, V., Supattapone, S., Serban, A., Cohen, F. E., Agard, D. A. & Prusiner, S. B. (2002). Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A 99, 3563-3568.